0001209191-22-039240.txt : 20220624 0001209191-22-039240.hdr.sgml : 20220624 20220624162821 ACCESSION NUMBER: 0001209191-22-039240 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220622 FILED AS OF DATE: 20220624 DATE AS OF CHANGE: 20220624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHAFFER CHRISTY L CENTRAL INDEX KEY: 0001145929 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 221040452 MAIL ADDRESS: STREET 1: INSPIRE PHARMACEUTICALS, INC., STREET 2: 4222 EMPEROR BLVD., STE. 470 CITY: DURHAM STATE: NC ZIP: 27703-8466 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-22 0 0001539029 Clearside Biomedical, Inc. CLSD 0001145929 SHAFFER CHRISTY L C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 0 0 0 Stock Option (right to buy) 1.62 2022-06-22 4 A 0 30000 0.00 A 2032-06-21 Common Stock 30000 30000 D The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2023. /s/ Mark Ballantyne, Attorney-in-Fact 2022-06-24